Search

everythinglearnresearchcommunity

for

Search:↓

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

The CAP1 gene helps control ammonium levels and is necessary for the proper growth of root hairs in Arabidopsis.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Minoxidil can reduce functions related to androgen receptors.

Thyroid receptor β can help develop new drugs to treat hair loss.

Whale oil significantly promotes hair growth and may be a safe, effective alternative to minoxidil.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Touch sensitivity in mouse skin decreases during hair growth due to changes in touch receptors.

Finding functions for unknown GPCRs is hard but key for making new drugs.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.

Some chemicals absorbed through the skin can cause serious health problems.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.